JAGX Jaguar Health
- 0.2950
- -0.0145-4.68%
Jaguar Health News
Peering Into Jaguar Health's Recent Short Interest
Jaguar Health's (NYSE:JAGX) short percent of float has fallen 29.87% since its last report. The company recently reported that it has 14.36 million shares sold short, which is 5.0% of all regular shar
Jaguar Health Announces Submission of Clinical Trial Applications for Crofelemer for the Rare Disease Indications Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome (SBS) in Europe
Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and SBSSAN FRANCISCO, CA / ACCESSWIRE / May
Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates
Click here to register for May 14 investor webcastCompany plans to file its Earnings Report on May 14, 2024 on Form 10-Q for the quarter ended March 31, 2024SAN FRANCISCO, CA / ACCESSWIRE / May 8, 202
FDA Conditionally Approves Jaguar Health's Prescription Drug Crofelemer For Chemotherapy-Induced Diarrhea In Dogs
Diarrhea is one of the most common reasons for veterinary visits for dogs and the second most common reason for visits to the veterinary emergency room, yet there are currently no FDA-approved anti-se
Jaguar Health (JAGX) Pre-market Surge Continues: Eyes on Elite Ped-GI Congress
In an unprecedented move, Jaguar Health, Inc. (NASDAQ: JAGX) sustained its remarkable momentum from Thursday, catapulting another 21% in premarket trading on Friday. Investors are witnessing an astonishing rally, with signs pointing towards further gains throughout the day. This surge comes amidst a lack of immediate news catalysts, fueling speculation of a potential profit-taking dip ...
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersHelius Medical Tech (NASDAQ:HSDT) shares increased by 48.9% to $3.96 during Friday's pre-market session. The company's market cap stands at $3.5 million. Vaxxinity (NASDAQ:VAXX) shares moved up
Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Shares of Apple Inc. (NASDAQ:AAPL) rose sharply in today's pre-market trading after the company reported better reported better-than-expected results for its second quarter.The company announced a $11
JAGX, SNSE and BON Among Mid-day Movers
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersEmergent BioSolutions (NYSE:EBS) stock moved upwards by 98.4% to $3.83 during Thursday's regular session. The company's market cap stands at $200.6 million. The company's, Q1 earnings came out
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Pediatric Gastroenterology Conference in Abu Dhabi and Panel Discussion About Microvillus Inclusion Disease (MVID)
Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and short bowel syndrome (SBS) with intestin
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.Nucor reported quarterly earnings of $3.46 per s
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersImmunityBio (NASDAQ:IBRX) shares moved upwards by 32.0% to $6.52 during Tuesday's pre-market session. The company's market cap stands at $4.4 billion. Nuwellis (NASDAQ:NUWE) shares increased by
Jaguar Health Shares Are Trading Lower After the Company Filed for a Mixed Shelf Offering of up to $75 Million.
Jaguar Health Shares Are Trading Lower After the Company Filed for a Mixed Shelf Offering of up to $75 Million.
Jaguar Health Inc Files For Mixed Shelf Offering Of Up To $75M
Jaguar Health Inc Files For Mixed Shelf Offering Of Up To $75M
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Vaxxinity, Inc. (NASDAQ:VAXX) fell sharply during Monday's session after the company announced its intention to voluntarily delist and deregister its Class A common stock.
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society...
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society (ONS) Congress in Support of Company's Expanding Focus on Cancer Supportive Care
Jaguar planning to begin commercial launch of FDA-approved Gelclair prescription gel for oral mucositis (also called "chemo mouth") in Q3 2024Company to feature "Make Cancer Less Shitty" patient advoc
Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company's In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care
Catherine Miller Collis was instrumental in bringing about Jaguar's recent in-license agreement for FDA-approved Gelclair, a protective gel for management of oral mucositis, a common, painful, and deb
Jaguar Stock Rallies 54% on Licensing Deal for Chemo Support Drug
Why Jaguar Health Stock Is Up Today
Jaguar Health, Inc. (NASDAQ:JAGX) shares are trading higher Tuesday after the company announced it has signed an exclusive 5-year in-license agreement with Venture Life Group PLC.The Details:The licen
Analysis
Price Target
No Data
